PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists engineer strain of MERS coronavirus for use in a vaccine

2013-09-10
(Press-News.org) Scientists have developed a strain of the Middle East respiratory syndrome coronavirus (MERS-CoV) that could be used as a vaccine against the disease, according to a study to be published in mBio®, the online open-access journal of the American Society for Microbiology. The mutant MERS virus, rMERS-CoV-ΔE, has a mutation in its envelope protein that makes it capable of infecting a cell and replicating its genetic material, but deprives it of the ability to spread to other tissues and cause disease. The authors say once additional safe guards are engineered into the virus, it could be used as the basis of a safe and effective live-attenuated vaccine against MERS.

"Our achievement was a combination of synthetic biology and genetic engineering," says co-author Luis Enjuanes of The Autonomous University of Madrid (Universidad Autónoma de Madrid).

"The injected vaccine will only replicate in a reduced number of cells and produce enough antigen to immunize the host," he says, and it cannot infect other people, even those in close contact with a vaccinated person.

Since MERS was first identified in June 2012, the World Health Organization has been notified of 108 cases of infection, including 50 deaths. Although the total number of cases is still relatively small, the case fatality rate and the spread of the virus to countries beyond the Middle East is alarming to public health officials. If the virus evolves the ability to transmit easily from person to person, a much more widespread epidemic is possible. Diagnostic assays and antiviral therapies for MERS have been described, but reliable vaccines have not yet been developed.

Enjuanes and his team applied what they had learned from 30 years of research on the molecular biology of coronaviruses to synthesize an infectious cDNA clone of the MERS-CoV genome based on a published sequence. They inserted the viral cDNA chromosome into a bacterial artificial chromosome, and mutated several of its genes, one by one, to study the effects on the virus' ability to infect, replicate, and re-infect cultured human cells.

Mutations that disabled accessory genes 3, 4a, 4b and 5 did not seem to hinder the virus: mutant viruses had similar growth rates as the wild-type virus, indicating that the mutations do not disable the virus enough to deploy the mutants in a vaccine. Mutations in the envelope protein (E protein), on the other hand, enabled the virus to replicate its genetic material, but prevented the virus from propagating, or infecting nearby cells.

A large amount of the rMERS-CoV-ΔE virus would be needed for a live attenuated MERS vaccine. A virus that can't propagate itself would be unable to grow the volume needed without help. Enjuanes says they provided the virus with a supplemental form E protein.

"To grow the virus, we create what are called 'packaging cells' that express the E protein missing in the virus. The gene to encode this protein is integrated in the cell chromosomes and will not mix with the viral genes. Therefore, in these cells, and only within them, the virus will grow by borrowing the E protein produced by the cell," says Enjuanes. "When the virus in administered to a person for vaccination, this person will not be able to provide the E protein to the defective virus," so the virus will die off after producing antigens to train the human immune system to fight a MERS-CoV infection.

Enjuanes says rMERS-CoV-ΔE is a very promising vaccine candidate, but more work remains before they can start clinical trials. He says the mutation in the E protein that prevents the virus from propagating represents one safe guard, but the US Food and Drug Administration requires that a recombinant live attenuated vaccine strains include at least three safe guards to ensure the virus doesn't revert easily back to its virulent form. His group is currently working on introducing other disabling mutations in genes that are located in regions of the virus' genome that are far away from the E protein gene to ensure the virus cannot revert back to virulence in a single recombination event.

###

mBio® is an open access online journal published by the American Society for Microbiology to make microbiology research broadly accessible. The focus of the journal is on rapid publication of cutting-edge research spanning the entire spectrum of microbiology and related fields. It can be found online at http://mbio.asm.org.

The American Society for Microbiology is the largest single life science society, composed of over 39,000 scientists and health professionals. ASM's mission is to advance the microbiological sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide.


ELSE PRESS RELEASES FROM THIS DATE:

Huge gaps in hypertension management

2013-09-09
A Simon Fraser University researcher studying hypertension rates in the U.S., Canada and England says each country needs to do more to prevent the condition, which is the leading risk factor for stroke and heart disease. "These data show that thousands of deaths could be prevented each year by improving blood pressure in Canada and other countries," says SFU Health Sciences professor Michel Joffres, the paper's lead author. "Hypertension is the number-one risk factor for mortality in the world, and small improvements in hypertension show important benefits in mortality, ...

Fruit flies demonstrate that diet experience can alter taste preferences, USCB study shows

2013-09-09
(Santa Barbara, Calif.) — If you've ever wondered how you learn to like a food you dislike, a new study conducted by UC Santa Barbara's Craig Montell, Duggan Professor of Neuroscience in the Department of Molecular, Cellular, and Developmental Biology, may offer an answer. The work addresses a central question in neurobiology — how experience can alter animal behavior. The research, just published in Nature Neuroscience, was conducted by Montell's team, which includes lead author Yali Zhang, Rakesh Raghuwanshi, and Wei Shen. Among the most widely observed, but poorly ...

Large international study of COPD drug finds 2 types of inhalers equally safe and effective

2013-09-09
An international study led by a Johns Hopkins pulmonary expert finds that the drug tiotropium (marketed as the Spiriva brand), can be delivered safely and effectively to people with chronic obstructive pulmonary disease (COPD) in both "mist" and traditional "dry powder" inhalers. The new Respimat inhaler, which delivers the drug in a mist form, is approved for use in Europe but not in the United States. The traditional inhaler, known as a HandiHaler, uses a dry powder form of the drug and is widely used in the U.S. The study comparing the two drug-delivery systems ...

Indy 500 track continues to foster better technology for everyday driving

2013-09-09
Contact: Michael Bernstein m_bernstein@acs.org 317-262-5907 (Indianapolis Press Center, Sept. 6-11) 202-872-6042 Michael Woods m_woods@acs.org 317-262-5907 (Indianapolis Press Center, Sept. 6-11) 202-872-6293 American Chemical Society Indy 500 track continues to foster better technology for everyday driving INDIANAPOLIS, Sept. 9, 2013 — The pavement recipe for the Indianapolis Motor Speedway (IMS), home of the Indianapolis 500, could be used to improve the smoothness, durability and safety of some of the 2 million miles of paved roads and streets where ...

The new allure of electric cars: Blazing-fast speeds

2013-09-09
Contact: Michael Bernstein m_bernstein@acs.org 317-262-5907 (Indianapolis Press Center, Sept. 6-11) 202-872-6042 Michael Woods m_woods@acs.org 317-262-5907 (Indianapolis Press Center, Sept. 6-11) 202-872-6293 American Chemical Society The new allure of electric cars: Blazing-fast speeds INDIANAPOLIS, Sept. 9, 2013 — Already noted for saving gasoline and having zero emissions, electric cars have quietly taken on an unlikely new dimension –– the ability to reach blazing speeds that rival the 0-to-60 performance of a typical Porsche or BMW, and compete on some ...

New research provides early indications that recycled sewage water is safe for crop irrigation

2013-09-09
Contact: Michael Bernstein m_bernstein@acs.org 317-262-5907 (Indianapolis Press Center, Sept. 6-11) 202-872-6042 Michael Woods m_woods@acs.org 317-262-5907 (Indianapolis Press Center, Sept. 6-11) 202-872-6293 American Chemical Society New research provides early indications that recycled sewage water is safe for crop irrigation INDIANAPOLIS, Sept. 9, 2013 — The first study under realistic field conditions has found reassuringly low levels of pharmaceuticals and personal care products (PPCPs) in crops irrigated with recycled sewage water, scientists ...

American Chemical Society presidential symposium: Career advancement opportunities

2013-09-09
Contact: Michael Bernstein m_bernstein@acs.org 317-262-5907 (Indianapolis Press Center, Sept. 6-11) 202-872-6042 Michael Woods m_woods@acs.org 317-262-5907 (Indianapolis Press Center, Sept. 6-11) 202-872-6293 American Chemical Society American Chemical Society presidential symposium: Career advancement opportunities INDIANAPOLIS, Sept. 9, 2013 — Even though the Great Recession officially ended more than three years ago in the U.S., lingering effects continue to impact careers for thousands of scientists. Advancing those careers for chemists and other ...

How bedbugs shrug off pesticides and simple measures to deal with it

2013-09-09
Contact: Michael Bernstein m_bernstein@acs.org 317-262-5907 (Indianapolis Press Center, Sept. 6-11) 202-872-6042 Michael Woods m_woods@acs.org 317-262-5907 (Indianapolis Press Center, Sept. 6-11) 202-872-6293 American Chemical Society How bedbugs shrug off pesticides and simple measures to deal with it INDIANAPOLIS, Sept. 9, 2013 — The bedbug's most closely guarded secrets — stashed away in protective armor that enables these blood-sucking little nasties to shrug off insecticides and thrive in homes and hotels — are on the agenda here today at a major ...

Advance in using biopsy samples in understanding environmental causes of cancer

2013-09-09
Contact: Michael Bernstein m_bernstein@acs.org 317-262-5907 (Indianapolis Press Center, Sept. 6-11) 202-872-6042 Michael Woods m_woods@acs.org 317-262-5907 (Indianapolis Press Center, Sept. 6-11) 202-872-6293 American Chemical Society Advance in using biopsy samples in understanding environmental causes of cancer INDIANAPOLIS, Sept. 9, 2013 — In an advance in determining the role of environmental agents in causing cancer, scientists today described development of a long-sought way to use biopsy samples from cancer patients to check on human exposure ...

Scientific symposium today on healthful antioxidants in plant-based foods

2013-09-09
Contact: Michael Bernstein m_bernstein@acs.org 317-262-5907 (Indianapolis Press Center, Sept. 6-11) 202-872-6042 Michael Woods m_woods@acs.org 317-262-5907 (Indianapolis Press Center, Sept. 6-11) 202-872-6293 American Chemical Society Scientific symposium today on healthful antioxidants in plant-based foods INDIANAPOLIS, Sept. 9, 2013 — With millions of people tailoring their diets to include more healthful antioxidants — and these "polyphenols" getting tremendous attention among nutritionists, food scientists and physicians — the world's largest ...

LAST 30 PRESS RELEASES:

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

Scientists uncover novel immune mechanism in wheat tandem kinase

Three University of Virginia Engineering faculty elected as AAAS Fellows

[Press-News.org] Scientists engineer strain of MERS coronavirus for use in a vaccine